CVRdatabase
Menu

Novo Nordisk Pharmatech A/S

Public limited companyCVR 13246149KøgeActive

Novo Nordisk Pharmatech A/S is a public limited company, based in Køge, active in manufacture of pharmaceutical preparations, founded in 1989. Net profit rose 88% from 2024 to 2025, ending at DKK 113.9m. Operations are spread over 3 production units. With 489 employees, the company is about 49 times larger than the industry median.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 1bn+8.9% vs. 2024
Net profitDKK 113.9m+87.9% vs. 2024
EquityDKK 2.4bn+83.9% vs. 2024
Employees489latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 337% (2024 → 2025), to DKK 74.9m.
  • Revenue rose 9% (2024 → 2025), to DKK 1bn.
  • Net profit rose 88% (2024 → 2025), to DKK 113.9m.
  • Equity rose 84% (2024 → 2025), to DKK 2.4bn.

Employees

  • 77 fewer employees than a year earlier: 489 (08/2026) against 566 (08/2025).

Management and owners, last 24 months

  • New in management: Christian Brøgger Stolberg (board member, 15/11/2024), Karina Sinding (board member, 12/03/2025) and Mette Sofie Mørck Jarl (chair of the board, 17/03/2026) (+1).
  • Stepped down: Zohra Mansour (board member, 14/11/2024), Jean Fabian Jeldorf (chair of the board, 17/03/2026) and Julie Aunbirk (board member, 12/03/2025) (+3).

Registrations, last 24 months

  • 04/06/2025: Share capital changed from 10,002,000 DKK to 10,003,000 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 500mDKK 1bnDKK 1.5bnDKK 2bnDKK 2.5bn202020212022202320242025
EquityNet profit
Financial figures for Novo Nordisk Pharmatech A/S
202020212022202320242025Change
Revenue667,729619,083598,265880,400956,0331,041,584+8.9%
Gross profit137,266141,06322,30051,17717,14774,863+336.6%
Operating profit (EBIT)153,939147,12041,87690,30173,479110,044+49.8%
Profit before tax146,169146,70849,25598,69177,296145,322+88%
Net profit114,915113,74839,30777,24760,619113,891+87.9%
Total assets745,525639,924966,9141,266,5621,962,7013,066,139+56.2%
Equity606,434520,247689,619766,9121,327,6202,441,318+83.9%
Liabilities–90,539––635,082624,821−1.6%
Cash and cash equivalents–00––0–
Average number of employees197212244336461529+14.8%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 20mDKK 40mDKK 60mDKK 80mDKK 100mDKK 120mDKK 140m202020212022202320242025
Gross profitMedian, the industry (59 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Novo Nordisk Pharmatech A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202509/04/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202416/04/2025The companyPDF not statedXBRL
202301/01/2023 – 31/12/202304/04/2024The companyPDF not statedXBRL
202201/01/2022 – 31/12/202231/03/2023The companyPDFXBRL
202101/01/2021 – 31/12/202128/04/2022The companyPDFXBRL
202001/01/2020 – 31/12/202022/03/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
010020030040050060009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

59 companies in the database

Comparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.

Gross profitDKK 74.9mNo. 12 of 57
Better than 80% of the companies in the industry
EquityDKK 2.4bnNo. 9 of 59
Better than 86% of the companies in the industry
Number of employees489No. 9 of 59
Better than 86% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.

DKK 266kDKK 8.3mDKK 258mDKK 8bnDKK 79.6bnHere
Distribution of gross profit for 34 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 200–499 employees796 companies in the comparison
No. 583of 763
Better than 24%
No. 27of 796
Better than 97%
Companies that are at least 30 years old10,276 companies in the comparison
No. 1,067of 10,152
Better than 89%
No. 102of 10,275
Better than 99%
All companies of type A/S18,025 companies in the comparison
No. 2,017of 17,786
Better than 89%
No. 199of 18,024
Better than 99%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of pharmaceutical preparations
Gross profit
  1. Novo Nordisk Pharmatech A/SDKK 74.9m
  2. Novo Nordisk A/SDKK 250.3bn
  3. H. Lundbeck A/SDKK 20.4bn
Net profit
  1. Novo Nordisk Pharmatech A/SDKK 113.9m
  2. Novo Nordisk A/SDKK 102.4bn
  3. H. Lundbeck A/SDKK 3.2bn
Equity
  1. Novo Nordisk Pharmatech A/SDKK 2.4bn
  2. Novo Nordisk A/SDKK 194bn
  3. H. Lundbeck A/SDKK 24.9bn
Employees
  1. Novo Nordisk Pharmatech A/S489
  2. Novo Nordisk A/S27,279
  3. H. Lundbeck A/S2,261

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Novo Nordisk Pharmatech A/S

Management

7 active registrations

Executive management

Executive management at Novo Nordisk Pharmatech A/S
NameRoleAppointed
Ulla Grove Krogsgaard ThomsenCEO01/04/2021

Board of directors

Board of directors at Novo Nordisk Pharmatech A/S
NameRoleAppointed
Joachim Juel HagemeisterBoard member13/05/2016
Tue MicheelsenBoard member01/10/2020
Jacob Sten PetersenBoard member01/06/2021
Christian Brøgger StolbergBoard member15/11/2024
Karina SindingBoard member12/03/2025
Mette Sofie Mørck JarlChair of the board17/03/2026
Founders
VX 10.312 ApS, Medimex ApS, ApS Hvkmd 5 Nr. 555, Pehsb ApS
Former management (60)
Former management at Novo Nordisk Pharmatech A/S
NameRoleAppointedResigned
Kurt Anker NielsenBoard member01/07/198904/02/1994
Bjarne Mølgaard KnudsenBoard member01/07/198929/05/2000
Jørgen Grønlund NielsenBoard member01/07/198904/02/1994
Ulf Svejgaard PoulsenBoard member01/07/198931/05/1990
Bjarne Tommy PedersenBoard member01/07/198912/10/1995
Bent Stig VaseBoard member01/07/198904/02/1994
Susanne Saul StakemannChair of the board01/07/198931/05/1990
Keld PedersenBoard member01/07/198901/05/1995
Hans Georg Boye NielsenBoard member01/07/198901/03/2000
Sonnich Jacob FrylandBoard member01/07/198920/11/1995
Per Emil Hasselbalch StakemannBoard member01/07/198931/05/1990
Per Emil Hasselbalch StakemannDirector01/07/198931/05/1990
Per AndersenBoard member01/07/198904/04/2001
Kjell Hans BakkeBoard member01/07/198904/02/1994
Jonna Annelise SkovagerBoard member01/07/198908/09/1993
Richardt SonnichsenBoard member01/07/198901/05/1995
Bente Hornbech GrubbeBoard member01/07/198912/10/1995
Jens Hartvig JørgensenBoard member01/07/198929/05/2000
Ole Regnar HansenBoard member01/07/198921/08/1997
Birgit MindegaardBoard member01/07/198931/08/1996
Kim Antero BjørnholtBoard member01/07/198901/03/2000
Preben Engelund PoulsenDirector01/07/198901/09/2003
Poul Lasse JespersenBoard member01/09/199601/03/2000
Steen Skjold-JørgensenBoard member21/08/199721/05/1999
Bente Margrethe Skov SchultzDeputy board member01/03/200016/04/2004
Erik Frederik Johannes MortensenBoard member01/03/200013/05/2016
Eva Kjer HansenBoard member01/03/200031/03/2008
Per Toft ValstorpChair of the board29/05/200023/01/2015
Ole Falvig RamsbyBoard member29/05/200001/11/2018
Jesper Giede BøvingBoard member29/05/200005/05/2009
Søren DamtoftDirector01/09/200301/09/2012
Kim Tosti NielsenBoard member23/01/200423/05/2007
Jesper Frank MorthensenDeputy board member16/04/200431/03/2008
Louise ThielDeputy board member16/04/200431/03/2008
Jesper KløveBoard member23/05/200709/02/2009
Poul Erik Noer SøderdahlDeputy board member31/03/200820/03/2012
Lars BjørkDeputy board member31/03/200820/03/2012
Susanne Møberg Hundsbæk-PedersenBoard member09/02/200909/02/2011
Jan HoffBoard member10/02/201223/01/2015
Lene Due SvenssonDeputy board member20/03/201224/09/2015
Henrik Kaj DvingeBoard member20/03/201218/03/2020
Camilla Mølbak SønderrisDeputy board member20/03/201213/05/2016
Rasmus Hother le FevreCEO01/09/201228/02/2021
Peter Helt Jacobsen HaahrBoard member03/09/201231/10/2016
Michael Fugl HallgrenBoard member23/01/201524/01/2019
Henrik Ehlers WulffChair of the board23/01/201515/05/2020
Vesna Maria SchneiderDeputy board member13/05/201618/03/2020
Lars SørensenDeputy board member13/05/201630/06/2018
Claus Steensen SøljeBoard member27/01/201718/03/2020
Søren Thor JensenBoard member01/11/201815/03/2023
Ulla Grove Krogsgaard ThomsenBoard member24/01/201901/04/2021
Knud Edgar Striib NielsenDeputy board member18/03/202011/03/2024
Jean Fabian JeldorfBoard member18/03/202014/05/2020
Zohra MansourBoard member18/03/202014/11/2024
Jean Fabian JeldorfChair of the board15/05/202017/03/2026
Bo Højriis FrandsenCEO01/03/202101/04/2021
Julie AunbirkBoard member15/03/202312/03/2025
Hazal PolatDeputy board member11/03/202430/05/2025
Christian Brøgger StolbergDeputy board member11/03/202414/11/2024
Mette Sofie Mørck JarlBoard member12/03/202516/03/2026

Signing rule: Selskabet tegnes af bestyrelsesformanden og direktøren i forening eller af bestyrelsesformanden og 1 medlem af bestyrelsen i forening eller af 3 bestyrelsesmedlemmer i forening eller af den samlede bestyrelse

Address and production units

3 active production units

Københavnsvej 216
4600 Køge

Køge Municipality · Postcode 4600

Open in OpenStreetMap
Production units
Production unitAddressEmployeesP number
Novo Nordisk Pharmatech A/SKøbenhavnsvej 216, 4600 Køge4891000528134
Novo Nordisk Pharmatech A/SÅdalen 16, 4600 Køge–1030631451
Novo Nordisk Pharmatech A/SKøbenhavnsvej 222, 4600 Køge–1029394853

Purpose

Selskabets formål er at drive handel og industri

The purpose is quoted from the register in Danish.

Changes year by year

131 registered events
20264 changesaccounts 1 · management 3
  • Annual report for 2025 published
  • Mette Sofie Mørck Jarl appointed chair of the board
  • Jean Fabian Jeldorf stepped down as chair of the board
  • Mette Sofie Mørck Jarl stepped down as board member
20256 changescapital 1 · management 4 · accounts 1
  • Share capital changed from 10,002,000 DKK to 10,003,000 DKK
  • Hazal Polat stepped down as deputy board member
  • Annual report for 2024 published
  • Mette Sofie Mørck Jarl appointed board member
  • Karina Sinding appointed board member
  • Julie Aunbirk stepped down as board member
20248 changesmanagement 6 · accounts 1 · capital 1
  • Christian Brøgger Stolberg appointed board member
  • Christian Brøgger Stolberg stepped down as deputy board member
  • Zohra Mansour stepped down as board member
  • Annual report for 2023 published
  • Christian Brøgger Stolberg appointed deputy board member
  • Hazal Polat appointed deputy board member
  • Knud Edgar Striib Nielsen stepped down as deputy board member
  • Share capital changed from 10,001,000 DKK to 10,002,000 DKK
20233 changesaccounts 1 · management 2
  • Annual report for 2022 published
  • Julie Aunbirk appointed board member
  • Søren Thor Jensen stepped down as board member
20222 changescapital 1 · accounts 1
  • Share capital changed from 10,000,000 DKK to 10,001,000 DKK
  • Annual report for 2021 published
20217 changesmanagement 6 · accounts 1
  • Jacob Sten Petersen appointed board member
  • Ulla Grove Krogsgaard Thomsen appointed ceo
  • Bo Højriis Frandsen stepped down as ceo
  • Ulla Grove Krogsgaard Thomsen stepped down as board member
  • Annual report for 2020 published
  • Bo Højriis Frandsen appointed ceo
  • Rasmus Hother le Fevre stepped down as ceo
202010 changesmanagement 10
  • Tue Micheelsen appointed board member
  • Jean Fabian Jeldorf appointed chair of the board
  • Henrik Ehlers Wulff stepped down as chair of the board
  • Jean Fabian Jeldorf stepped down as board member
  • Knud Edgar Striib Nielsen appointed deputy board member
  • Zohra Mansour appointed board member
  • Jean Fabian Jeldorf appointed board member
  • Claus Steensen Sølje stepped down as board member
  • Vesna Maria Schneider stepped down as deputy board member
  • Henrik Kaj Dvinge stepped down as board member
20192 changesmanagement 2
  • Ulla Grove Krogsgaard Thomsen appointed board member
  • Michael Fugl Hallgren stepped down as board member
20183 changesmanagement 3
  • Søren Thor Jensen appointed board member
  • Ole Falvig Ramsby stepped down as board member
  • Lars Sørensen stepped down as deputy board member
20171 changemanagement 1
  • Claus Steensen Sølje appointed board member
20166 changesmanagement 6
  • Peter Helt Jacobsen Haahr stepped down as board member
  • Vesna Maria Schneider appointed deputy board member
  • Joachim Juel Hagemeister appointed board member
  • Lars Sørensen appointed deputy board member
  • Camilla Mølbak Sønderris stepped down as deputy board member
  • Erik Frederik Johannes Mortensen stepped down as board member
20156 changesmanagement 5 · name 1
  • Lene Due Svensson stepped down as deputy board member
  • Name changed from FEF CHEMICALS A/S to Novo Nordisk Pharmatech A/S
  • Henrik Ehlers Wulff appointed chair of the board
  • Michael Fugl Hallgren appointed board member
  • Jan Hoff stepped down as board member
  • Per Toft Valstorp stepped down as chair of the board
20129 changesmanagement 9
  • Peter Helt Jacobsen Haahr appointed board member
  • Rasmus Hother le Fevre appointed ceo
  • Søren Damtoft stepped down as director
  • Henrik Kaj Dvinge appointed board member
  • Camilla Mølbak Sønderris appointed deputy board member
  • Lene Due Svensson appointed deputy board member
  • Lars Bjørk stepped down as deputy board member
  • Poul Erik Noer Søderdahl stepped down as deputy board member
  • Jan Hoff appointed board member
20111 changemanagement 1
  • Susanne Møberg Hundsbæk-Pedersen stepped down as board member
20093 changesmanagement 3
  • Jesper Giede Bøving stepped down as board member
  • Susanne Møberg Hundsbæk-Pedersen appointed board member
  • Jesper Kløve stepped down as board member
20086 changesmanagement 5 · industry 1
  • Lars Bjørk appointed deputy board member
  • Poul Erik Noer Søderdahl appointed deputy board member
  • Louise Thiel stepped down as deputy board member
  • Jesper Frank Morthensen stepped down as deputy board member
  • Eva Kjer Hansen stepped down as board member
  • Industry changed to Manufacture of pharmaceutical preparations (212000)
20072 changesmanagement 2
  • Jesper Kløve appointed board member
  • Kim Tosti Nielsen stepped down as board member
20044 changesmanagement 4
  • Louise Thiel appointed deputy board member
  • Jesper Frank Morthensen appointed deputy board member
  • Bente Margrethe Skov Schultz stepped down as deputy board member
  • Kim Tosti Nielsen appointed board member
20032 changesmanagement 2
  • Søren Damtoft appointed director
  • Preben Engelund Poulsen stepped down as director
20012 changesmanagement 1 · industry 1
  • Per Andersen stepped down as board member
  • Industry changed to Aluminium production (244200)
200010 changesmanagement 10
  • Ole Falvig Ramsby appointed board member
  • Per Toft Valstorp appointed chair of the board
  • Jesper Giede Bøving appointed board member
  • Bjarne Mølgaard Knudsen stepped down as board member
  • Erik Frederik Johannes Mortensen appointed board member
  • Bente Margrethe Skov Schultz appointed deputy board member
  • Eva Kjer Hansen appointed board member
  • Poul Lasse Jespersen stepped down as board member
  • Hans Georg Boye Nielsen stepped down as board member
  • Kim Antero Bjørnholt stepped down as board member
19991 changemanagement 1
  • Steen Skjold-Jørgensen stepped down as board member
19971 changemanagement 1
  • Steen Skjold-Jørgensen appointed board member
19961 changemanagement 1
  • Poul Lasse Jespersen appointed board member
19953 changesmanagement 3
  • Sonnich Jacob Fryland stepped down as board member
  • Bjarne Tommy Pedersen stepped down as board member
  • Keld Pedersen stepped down as board member
19944 changesmanagement 3 · capital 1
  • Bent Stig Vase stepped down as board member
  • Jørgen Grønlund Nielsen stepped down as board member
  • Kurt Anker Nielsen stepped down as board member
  • Share capital changed from 5,000,000 DKK to 10,000,000 DKK
19921 changename 1
  • Name changed from FERROSAN FINE CHEMICALS A/S to FEF CHEMICALS A/S
19906 changesname 1 · capital 1 · management 4
  • Name changed from A/S PSE NR. 3369 to FERROSAN FINE CHEMICALS A/S
  • Share capital changed from 300,000 DKK to 5,000,000 DKK
  • Per Emil Hasselbalch Stakemann stepped down as director
  • Per Emil Hasselbalch Stakemann stepped down as board member
  • Susanne Saul Stakemann stepped down as chair of the board
  • Ulf Svejgaard Poulsen stepped down as board member
198917 changesfounded 1 · management 15 · ownership 1
  • Registered as A/S PSE NR. 3369
  • Per Andersen appointed board member
  • Per Emil Hasselbalch Stakemann appointed director
  • Per Emil Hasselbalch Stakemann appointed board member
  • Sonnich Jacob Fryland appointed board member
  • Hans Georg Boye Nielsen appointed board member
  • Keld Pedersen appointed board member
  • Susanne Saul Stakemann appointed chair of the board
  • Bent Stig Vase appointed board member
  • Bjarne Tommy Pedersen appointed board member
  • Ulf Svejgaard Poulsen appointed board member
  • Jørgen Grønlund Nielsen appointed board member
  • Kurt Anker Nielsen appointed board member
  • Bjarne Mølgaard Knudsen appointed board member
  • Preben Engelund Poulsen appointed director
  • Kim Antero Bjørnholt appointed board member
  • NOVO NORDISK A/S registered as owner (100%)

Related companies

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 23/10/2026.

View in CVRReport a correction